KIDRON NADAV — SEC insider filings
SEC reporting owner CIK 1351779. 28 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2021-02-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 126,000 shares, $254,014 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 440,000 shares, $8,846,288 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 47.
- Largest priced transaction: sale of 220,000 shares @ $20.11 ($4,423,144) in ORAMED PHARMACEUTICALS INC., filed 2021-12-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO, Director | 26 | 2 legs · 126,000 sh · $254,014 | 2 legs · 440,000 sh · $8,846,288 | 44 |
| Nano Dimension Ltd. (NNDM) | Director | 1 | — | — | 2 |
| Lifeward Ltd. (LFWD) | Director | 1 | — | — | 1 |
Insider filings — KIDRON NADAV
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 629,000 · Grant/award (A): 688,000 | EDGAR |
| 2026-09-25 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 349,497 · Grant/award (A): 368,765 · Disposition to issuer (D): 196,500 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Disposition to issuer (D): 49,000 (derivative) · Disposition to issuer (D): 97,000 (derivative) · +2 more | EDGAR |
| 2026-08-25 | 4 | Nano Dimension Ltd. (NNDM) | Option exercise/expiry (X): 10,000 @ $1.50 · Option exercise/expiry (X): 100 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Tax withholding (F): 44,818 @ $3.31 | EDGAR |
| 2026-03-27 | 4 | Lifeward Ltd. (LFWD) | Grant/award (A): 7,657 @ $0 | EDGAR |
| 2026-03-18 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 167,005 @ $0 | EDGAR |
| 2026-03-16 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 100,000 @ $0 | EDGAR |
| 2026-01-29 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 109,000 @ $0 · Option exercise (M): 109,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 232,640 @ $0 · Grant/award (A): 327,000 @ $0 · Grant/award (A): 109,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 141,000 @ $0 · Grant/award (A): 186,000 @ $0 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-01-06 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 433,500 | EDGAR |
| 2024-11-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 45,000 | EDGAR |
| 2024-01-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 329,000 | EDGAR |
| 2023-05-31 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 120,000 | EDGAR |
| 2023-04-20 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 279,000 | EDGAR |
| 2023-03-16 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Purchase (P): 26,000 @ $2.04 | EDGAR |
| 2023-03-15 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Purchase (P): 100,000 @ $2.01 | EDGAR |
| 2022-10-28 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 25,000 @ $0 | EDGAR |
| 2022-08-01 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 34,000 · Grant/award (A): 126,000 · Tax withholding (F): 12,631 @ $8.36 | EDGAR |
| 2022-01-11 | 4/A | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 150,000 · Tax withholding (F): 48,752 @ $13.89 · Grant/award (A): 63,000 · Grant/award (A): 107,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 150,000 · Tax withholding (F): 48,752 @ $13.89 · Grant/award (A): 63,000 · Grant/award (A): 107,000 (derivative) @ $0 | EDGAR |
| 2021-12-30 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Tax withholding (F): 31,728 @ $12.98 · Gift (G): 20,000 | EDGAR |
| 2021-12-07 | 4/A | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 100,000 | EDGAR |
| 2021-12-07 | 4/A | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 220,000 @ $20.11 | EDGAR |
| 2021-12-07 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 20,000 | EDGAR |
| 2021-09-02 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 100,000 | EDGAR |
| 2021-08-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 220,000 @ $20.11 | EDGAR |
| 2021-02-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1351779 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs